{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:35:37Z","timestamp":1786448137899,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Functional visual loss is a common issue in neuro-ophthalmology settings. There are many studies focused on diagnosis, but there is limited literature on associated epidemiology, phenomenology, prognosis and treatment. We carried out the first systematic review and meta-analysis assessing these domains. We systematically reviewed PubMed from 1951 for studies reporting clinical data on adults and children with functional visual loss. Data on variables relevant to epidemiology, phenomenology, comorbidity, risk factors, prognosis and treatment were extracted. Random effects meta-analyses were performed where appropriate. Forty-four studies of functional visual loss (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20092284, 67% female) were included. The pooled median age was 43 years (IQR 12.5\u201343 years). Common associations included facial\/ocular trauma (19%,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009288), ocular comorbidity (25%,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009470), headache (39%,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009124) and other functional symptom\/disorder (10\u201329%). Good quality data on psychiatric comorbidity and adverse childhood experience were unavailable. Prognosis data (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091019, 13 studies) were heterogeneous, but outcome appeared more favourable in paediatric studies. Most studies did not distinguish between symptomatic visual loss and functional visual signs which are asymptomatic (such as spiralled fields) or disproportionate to symptoms (such as severe acuity loss in someone with minor visual symptoms). There are very limited data on treatment. This systematic review highlights some basic epidemiological data and relevant aetiological factors in functional visual loss but also the significant gaps that must be addressed to improve care for this disabling condition.\n                  <\/jats:p>","DOI":"10.1038\/s41433-026-04648-1","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:35:07Z","timestamp":1782480907000},"page":"1784-1793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional visual loss: a systematic review and meta-analysis of epidemiology, prognosis and treatment"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3179-8126","authenticated-orcid":false,"given":"Neil","family":"Ramsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7414-6780","authenticated-orcid":false,"given":"Helena","family":"Tessmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Ercoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9829-8092","authenticated-orcid":false,"given":"Jon","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"4648_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/jnnp-2024-334767","volume":"96","author":"SA Finkelstein","year":"2025","unstructured":"Finkelstein SA, Diamond C, Carson A, Stone J. Incidence and prevalence of functional neurological disorder: a systematic review. J Neurol Neurosurg Psychiatry. 2025;96:383\u201395.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4648_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1474-4422(21)00422-1","volume":"21","author":"M Hallett","year":"2022","unstructured":"Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J. Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neurol. 2022;21:537\u201350.","journal-title":"Lancet Neurol"},{"key":"4648_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41582-022-00765-z","volume":"19","author":"MJ Edwards","year":"2023","unstructured":"Edwards MJ, Yogarajah M, Stone J. Why functional neurological disorder is not feigning or malingering. Nat Rev Neurol. 2023;19:246\u201356.","journal-title":"Nat Rev Neurol"},{"key":"4648_CR4","doi-asserted-by":"crossref","unstructured":"Dattilo M, Biousse V, Bruce BB, Newman NJ. Functional and simulated visual loss. In: Handbook of Clinical Neurology. Hallett M, Stone J. Elsevier; 2016. 329\u201349.","DOI":"10.1016\/B978-0-12-801772-2.00029-1"},{"key":"4648_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/ICU.0b013e328358c6dc","volume":"23","author":"J Pula","year":"2012","unstructured":"Pula J. Functional vision loss. Curr Opin Ophthalmol. 2012;23:460\u20135.","journal-title":"Curr Opin Ophthalmol"},{"key":"4648_CR6","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/bjo-2023-324856","volume":"108","author":"BKL Tao","year":"2024","unstructured":"Tao BKL, Xie JS, Margolin E. Functional vision disorder: a review of diagnosis, management and costs. Br J Ophthalmol. 2024;108:1479\u201385.","journal-title":"Br J Ophthalmol"},{"key":"4648_CR7","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/s41433-024-03126-w","volume":"38","author":"N Ramsay","year":"2024","unstructured":"Ramsay N, McKee J, Al-Ani G, Stone J. How do I manage functional visual loss. Eye. 2024;38:2257\u201366.","journal-title":"Eye"},{"key":"4648_CR8","unstructured":"Carolyn Sleith. Scottish Intercollegiate Guideline Network (SIGN). 2012. Scottish Intercollegiate Guideline Network (SIGN): Notes on Methodology Checklist 4: Case Control Studies."},{"key":"4648_CR9","unstructured":"Carolyn Sleith. Scottish Intercollegiate Guideline Network (SIGN). 2012. Scottish Intercollegiate Guideline Network (SIGN): Notes on Methodology Checklist 3: Cohort Studies."},{"key":"4648_CR10","unstructured":"Posit team. http:\/\/www.posit.co\/.2024. RStudio: Integrated Development Environment for R. Posit Software, PBC, Boston, MA."},{"key":"4648_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF00161025","volume":"82","author":"MC Barris","year":"1992","unstructured":"Barris MC, Kaufman DI, Barberio D. Visual impairment in hysteria. Doc Ophthalmol. 1992;82:369\u201382.","journal-title":"Doc Ophthalmol"},{"key":"4648_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1212\/WNL.32.7.757","volume":"32","author":"JR Keane","year":"1982","unstructured":"Keane JR. Neuro-ophthalmic signs and symptoms of hysteria. Neurology. 1982;32:757\u201362.","journal-title":"Neurology"},{"key":"4648_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/archopht.1968.03850040256006","volume":"79","author":"AE Krill","year":"1968","unstructured":"Krill AE, Newell FW. The diagnosis of ocular conversion reaction involving visual function. Arch Ophthalmol. 1968;79:254\u201361.","journal-title":"Arch Ophthalmol"},{"key":"4648_CR14","first-page":"347","volume":"103","author":"D Gale","year":"1983","unstructured":"Gale D. Visual field defects in medico-legal cases. Trans Ophthalmol Soc U K. 1983;103:347\u201350.","journal-title":"Trans Ophthalmol Soc U K"},{"key":"4648_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/archopht.1983.01040010729005","volume":"101","author":"RG Kathol","year":"1983","unstructured":"Kathol RG. Functional visual loss. Arch Ophthalmol. 1983;101:729.","journal-title":"Arch Ophthalmol"},{"key":"4648_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/bjo.53.12.839","volume":"53","author":"J Behrman","year":"1969","unstructured":"Behrman J. The visual evoked response in hysterical amblyopia. Br J Ophthalmol. 1969;53:839\u201345.","journal-title":"Br J Ophthalmol"},{"key":"4648_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1055\/s-2001-18390","volume":"218","author":"A Langmann","year":"2001","unstructured":"Langmann A, Lindner S, Kriechbaum N. Funktionelle Sehst\u00f6rung als Konversionssymptom im Kindes- und Jugendalter. Klin Monbl Augenheilkd. 2001;218:677\u201381.","journal-title":"Klin Monbl Augenheilkd"},{"key":"4648_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3928\/0191-3913-20010101-08","volume":"38","author":"E Saitoh","year":"2001","unstructured":"Saitoh E, Adachi-Usami E, Mizota A, Fujimoto N. Comparison of visual evoked potentials in patients with psychogenic visual disturbance and malingering. J Pediatr Ophthalmol Strabismus. 2001;38:21\u20136.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"4648_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1755-3768.1989.tb00746.x","volume":"67","author":"O Sletteberg","year":"1989","unstructured":"Sletteberg O, Bertelsen T, H\u00f8vding G. The prognosis of patients with hysterical visual impairment. Acta Ophthalmol. 1989;67:159\u201363.","journal-title":"Acta Ophthalmol"},{"key":"4648_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0161-6420(86)33730-8","volume":"93","author":"RA Catalano","year":"1986","unstructured":"Catalano RA, Simon JW, Krohel GB, Rosenberg PN. Functional visual loss in children. Ophthalmology. 1986;93:385\u201390.","journal-title":"Ophthalmology"},{"key":"4648_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0161-6420(85)34020-4","volume":"92","author":"JL Keltner","year":"1985","unstructured":"Keltner JL, May WN, Johnson CA, Post RB. The California syndrome. Functional visual complaints with potential economic impact. Ophthalmol. 1985;92:427\u201335.","journal-title":"Ophthalmol"},{"key":"4648_CR22","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/eye.2000.201","volume":"14","author":"KE Bain","year":"2000","unstructured":"Bain KE, Beatty S, Lloyd C. Non-organic visual loss in children. Eye. 2000;14:770\u20132. Sep.","journal-title":"Eye"},{"key":"4648_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2190\/7LG4-6TB4-W4Q8-HCMQ","volume":"2","author":"MP Gross","year":"1971","unstructured":"Gross MP, Sloan SH. Patients with eye symptoms and no organic illness: an interdisciplinary study. Psychiatry Med. 1971;2:298\u2013307.","journal-title":"Psychiatry Med"},{"key":"4648_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0033-3182(73)71319-0","volume":"14","author":"RT Rada","year":"1973","unstructured":"Rada RT, Krill AE, Meyer GG, Armstrong D. Visual conversion reaction in children. Psychosomatics. 1973;14:271\u20136.","journal-title":"Psychosomatics"},{"key":"4648_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/112067219100100302","volume":"1","author":"MJ Drinnan","year":"1991","unstructured":"Drinnan MJ, Marmor MF. Functional visual loss in cambodian refugees: a study of cultural factors in ophthalmology. Eur J Ophthalmol. 1991;1:115\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"4648_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/1359104500005002009","volume":"5","author":"K Abe","year":"2000","unstructured":"Abe K, Suzuki T. Functional visual loss in childhood and suggestibility. Clin Child Psychol Psychiatry. 2000;5:239\u201346.","journal-title":"Clin Child Psychol Psychiatry"},{"key":"4648_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0022-3999(70)90029-2","volume":"14","author":"J Behrman","year":"1970","unstructured":"Behrman J, Levy R. Neurophysiological studies on patients with hysterical disturbances of vision. J Psychosom Res. 1970;14:187\u201394.","journal-title":"J Psychosom Res"},{"key":"4648_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1212\/01.wnl.0000287090.98555.56","volume":"70","author":"R Bengtzen","year":"2008","unstructured":"Bengtzen R, Woodward M, Lynn MJ, Newman NJ, Biousse V. The \u201csunglasses sign\u201d predicts nonorganic visual loss in neuro-ophthalmologic practice. Neurology. 2008;70:218\u201321.","journal-title":"Neurology"},{"key":"4648_CR29","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/eye.2017.37","volume":"31","author":"MC Daniel","year":"2017","unstructured":"Daniel MC, Coughtrey A, Heyman I, Dahlmann-Noor AH. Medically unexplained visual loss in children and young people: an observational single site study of incidence and outcomes. Eye. 2017;31:1068\u201373.","journal-title":"Eye"},{"key":"4648_CR30","first-page":"305","volume":"7","author":"R Foroozan","year":"2012","unstructured":"Foroozan R. Non-organic visual loss in patients with multifocal intraocular lenses. J Ophthalmic Vis Res. 2012;7:305\u20139.","journal-title":"J Ophthalmic Vis Res"},{"key":"4648_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/aos.12405","volume":"92","author":"L Fris\u00e9n","year":"2014","unstructured":"Fris\u00e9n L. Identification of functional visual field loss by automated static perimetry. Acta Ophthalmol. 2014;92:805\u20139.","journal-title":"Acta Ophthalmol"},{"key":"4648_CR32","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/0002-9394(66)92560-8","volume":"62","author":"H Friesen","year":"1966","unstructured":"Friesen H, Mann WA. Follow-up study of hysterical amblyopia. Am J Ophthalmol. 1966;62:1106\u201315.","journal-title":"Am J Ophthalmol"},{"key":"4648_CR33","first-page":"684","volume":"13","author":"M Kinori","year":"2011","unstructured":"Kinori M, Wygnanski-Jaffe T, Huna-Baron R. Functional visual loss in an Israeli pediatric population. Isr Med Assoc J. 2011;13:684\u20138.","journal-title":"Isr Med Assoc J"},{"key":"4648_CR34","first-page":"197","volume":"18","author":"SE Kyung","year":"2014","unstructured":"Kyung SE, Lee SM, Lim MH. Child behavior check list and Korean personality inventory for children with functional visual loss. Int J Psychiatry Clin Pr. 2014;18:197\u2013202.","journal-title":"Int J Psychiatry Clin Pr"},{"key":"4648_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3341\/jkos.2016.57.9.1435","volume":"57","author":"SH Lee","year":"2016","unstructured":"Lee SH, Shin KS, Lee YH. The clinical features and the prognosis of functional visual loss in children. J Korean Ophthalmol Soc. 2016;57:1435.","journal-title":"J Korean Ophthalmol Soc"},{"key":"4648_CR36","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.ophtha.2005.05.009","volume":"112","author":"SA Lim","year":"2005","unstructured":"Lim SA, Siatkowski RM, Farris BK. Functional visual loss in adults and children patient characteristics, management, and outcomes. Ophthalmology. 2005;112:1821\u20138.","journal-title":"Ophthalmology"},{"key":"4648_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5301\/EJO.2011.8378","volume":"22","author":"AM Mu\u00f1oz-Hern\u00e1ndez","year":"2012","unstructured":"Mu\u00f1oz-Hern\u00e1ndez AM, Santos-Bueso E, S\u00e1enz-Franc\u00e9s F, M\u00e9ndez-Hern\u00e1ndez CD, Garc\u00eda-Feijo\u00f3 J, Geg\u00fandez-Fern\u00e1ndez JA, et al. Nonorganic visual loss and associated psychopathology in children. Eur J Ophthalmol. 2012;22:269\u201373.","journal-title":"Eur J Ophthalmol"},{"key":"4648_CR38","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.ophtha.2009.03.056","volume":"116","author":"JJ Ney","year":"2009","unstructured":"Ney JJ, Volpe NJ, Liu GT, Balcer LJ, Moster ML, Galetta SL. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology. 2009;116:1808\u201313.e1.","journal-title":"Ophthalmology"},{"key":"4648_CR39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jns.2015.12.045","volume":"361","author":"\u00c9D O\u2019Leary","year":"2016","unstructured":"O\u2019Leary \u00c9D, McNeillis B, Aybek S, Riordan-Eva P, David AS. Medically unexplained visual loss in a specialist clinic: a retrospective case\u2013control comparison. J Neurol Sci. 2016;361:272\u20136.","journal-title":"J Neurol Sci"},{"key":"4648_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neucli.2014.04.004","volume":"44","author":"D Parain","year":"2014","unstructured":"Parain D, Chastan N. Large-field repetitive transcranial magnetic stimulation with circular coil in the treatment of functional neurological symptoms. Neurophysiologie Clin\/Clin Neurophysiol. 2014;44:425\u201331.","journal-title":"Neurophysiologie Clin\/Clin Neurophysiol"},{"key":"4648_CR41","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S0002-9394(02)02254-7","volume":"135","author":"JA Scott","year":"2003","unstructured":"Scott JA, Egan RA. Prevalence of organic Neuro-ophthalmologic disease in patients with functional visual loss. Am J Ophthalmol. 2003;135:670\u20135.","journal-title":"Am J Ophthalmol"},{"key":"4648_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/0883073810373947","volume":"26","author":"A Suppiej","year":"2011","unstructured":"Suppiej A, Gaspa G, Cappellari A, Toldo I, Battistella PA. The role of visual evoked potentials in the differential diagnosis of functional visual loss and optic neuritis in children. J Child Neurol. 2011;26:58\u201364.","journal-title":"J Child Neurol"},{"key":"4648_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaapos.2004.06.006","volume":"8","author":"A Taich","year":"2004","unstructured":"Taich A, Crowe S, Kosmorsky GS, Traboulsi EI. Prevalence of psychosocial disturbances in children with nonorganic visual loss. J Am Assoc Pediatr Ophthalmol Strabismus. 2004;8:457\u201361.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"4648_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/WNO.0b013e3181c252b9","volume":"30","author":"I Toldo","year":"2010","unstructured":"Toldo I, Pinello L, Suppiej A, Ermani M, Cermakova I, Zanin E, et al. Nonorganic (psychogenic) visual loss in children: a retrospective series. J Neuro-Ophthalmol. 2010;30:26\u201330.","journal-title":"J Neuro-Ophthalmol"},{"key":"4648_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1469-7610.1997.tb01521.x","volume":"38","author":"S Wynick","year":"1997","unstructured":"Wynick S, Hobson RP, Jones RB. Psychogenic disorders of vision in childhood (\u201cVisual Conversion Reactions\u201d): perspectives from adolescence: a research note. J Child Psychol Psychiatry. 1997;38:375\u20139.","journal-title":"J Child Psychol Psychiatry"},{"key":"4648_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0161-6420(00)00478-4","volume":"108","author":"S Xu","year":"2001","unstructured":"Xu S, Meyer D, Yoser S, Mathews D, Elfervig JL. Pattern visual evoked potential in the diagnosis of functional visual loss11The authors have no proprietary interest in any of the materials used in this study. Ophthalmology. 2001;108:76\u201380.","journal-title":"Ophthalmology"},{"key":"4648_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/archopht.1951.01700010073009","volume":"45","author":"ER Yasuna","year":"1951","unstructured":"Yasuna ER. Hysterical amblyopia in children and young adults. Arch Ophthalmol. 1951;45:70\u20136.","journal-title":"Arch Ophthalmol"},{"key":"4648_CR48","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/bjo.2008.154922","volume":"93","author":"MS Zinkernagel","year":"2009","unstructured":"Zinkernagel MS, Pellanda N, Kunz A, Mojon DS. Saccade testing to distinguish between non-organic and organic visual-field restriction. Br J Ophthalmol. 2009;93:1247\u201350.","journal-title":"Br J Ophthalmol"},{"key":"4648_CR49","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1055\/a-1778-4693","volume":"239","author":"L Sisera","year":"2022","unstructured":"Sisera L, Patzelt S, Gerth-Kahlert C. Nicht organische Sehst\u00f6rungen bei Kindern und Jugendlichen. Klin Monbl Augenheilkd. 2022;239:599\u2013604.","journal-title":"Klin Monbl Augenheilkd"},{"key":"4648_CR50","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.2147\/OPTH.S212365","volume":"13","author":"M Takahashi","year":"2019","unstructured":"Takahashi M, Kunikata H, Kato K, Kawakami A, Nakazawa T. Familial background factors and their association with non-organic visual loss. Clin Ophthalmol. 2019;13:2059\u201361.","journal-title":"Clin Ophthalmol"},{"key":"4648_CR51","doi-asserted-by":"publisher","first-page":"e727","DOI":"10.1016\/j.jcjo.2024.02.018","volume":"59","author":"M Lawlor","year":"2024","unstructured":"Lawlor M, Huynh B, Humphreys K, Ogunbowale L, Kopelman MD, Plant GT. Observational cohort study of 100 patients presenting with functional visual loss: clinical characteristics and comparison with other functional neurologic disorders. Can J Ophthalmol. 2024;59:e727\u201336.","journal-title":"Can J Ophthalmol"},{"key":"4648_CR52","first-page":"477","volume":"121","author":"VC Br\u00fccher","year":"2024","unstructured":"Br\u00fccher VC, Timm MJ, Grenzebach U, Eter N, Biermann J. Features of non-organic visual loss in childhood\u2014a retrospective, single-center analysis. Dtsch Arztebl Int. 2024;121:477\u20138.","journal-title":"Dtsch Arztebl Int"},{"key":"4648_CR53","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ajo.2023.02.005","volume":"250","author":"I Sverdlichenko","year":"2023","unstructured":"Sverdlichenko I, Brossard-Barbosa N, Micieli JA, Margolin E. Characteristics of 110 patients with functional visual loss. Am J Ophthalmol. 2023;250:171\u20136.","journal-title":"Am J Ophthalmol"},{"key":"4648_CR54","doi-asserted-by":"publisher","unstructured":"Somers A, Casteels K, Van Roie E, Spileers W, Casteels I Non-organic visual loss in children: prospective and retrospective analysis of associated psychosocial problems and stress factors. Acta Ophthalmol. 2016;94. https:\/\/doi.org\/10.1111\/aos.12848.","DOI":"10.1111\/aos.12848"},{"key":"4648_CR55","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.ophtha.2007.04.026","volume":"114","author":"FC Gundogan","year":"2007","unstructured":"Gundogan FC, Sobaci G, Bayer A. Pattern visual evoked potentials in the assessment of visual acuity in malingering. Ophthalmology. 2007;114:2332\u20137.e1.","journal-title":"Ophthalmology"},{"key":"4648_CR56","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archopht.1955.00930020881011","volume":"54","author":"T Schlaegel","year":"1955","unstructured":"Schlaegel T. Quilala F V. Hysterical amblyopia; statistical analysis of forty-two cases found in a survey of eight hundred unselected eye patients at a state medical center. AMA Arch Ophthalmol. 1955;54:875\u201384.","journal-title":"AMA Arch Ophthalmol"},{"key":"4648_CR57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/WNO.0b013e31820a45b2","volume":"31","author":"N Ali","year":"2011","unstructured":"Ali N. Functional constriction of the ocular motor field: description and preliminary evaluation of a new technique to help distinguish organic from nonorganic visual field loss. J Neuro-Ophthalmol. 2011;31:131\u20134.","journal-title":"J Neuro-Ophthalmol"},{"key":"4648_CR58","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1212\/WNL.51.4.1230","volume":"51","author":"JR Keane","year":"1998","unstructured":"Keane JR. Patterns of hysterical hemianopia. Neurology. 1998;51:1230\u20131.","journal-title":"Neurology"},{"key":"4648_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0919-2","volume":"19","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. European Headache Federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19:93.","journal-title":"J Headache Pain"},{"key":"4648_CR60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/02646196231195703","volume":"42","author":"R Schraauwers","year":"2024","unstructured":"Schraauwers R, Ketelaar M, Sterkenburg P. Bibliometric mapping of current therapies for children and adolescents with a functional visual disorder (FVD). Br J Vis Impairment. 2024;42:225\u201336.","journal-title":"Br J Vis Impairment"},{"key":"4648_CR61","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00417-021-05433-4","volume":"260","author":"M Laginaf","year":"2022","unstructured":"Laginaf M, Costello H, Price G. How do ophthalmologists manage functional visual symptoms? A UK survey of ophthalmologists\u2019 experience. Graefe\u2019s Arch Clin Exp Ophthalmol. 2022;260:1307\u201313.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"4648_CR62","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/jnnp-2021-328462","volume":"93","author":"SC Lidstone","year":"2022","unstructured":"Lidstone SC, Costa-Parke M, Robinson EJ, Ercoli T, Stone J. Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases. J Neurol Neurosurg Psychiatry. 2022;93:609\u201316.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4648_CR63","doi-asserted-by":"publisher","unstructured":"Stone J, Coebergh J, Khoja L, Butler M, Nicholson TR, Dodick DW Migraine and functional neurological disorder (FND)\u2014a review of comorbidity and potential overlap. Brain Commun. 2025;7. https:\/\/doi.org\/10.1093\/braincomms\/fcaf288.","DOI":"10.1093\/braincomms\/fcaf288"},{"key":"4648_CR64","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/brain\/awq068","volume":"133","author":"J Stone","year":"2010","unstructured":"Stone J, Warlow C, Sharpe M. The symptom of functional weakness: a controlled study of 107 patients. Brain. 2010;133:1537\u201351.","journal-title":"Brain"},{"key":"4648_CR65","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/practneurol-2018-002092","volume":"19","author":"JM Yeo","year":"2019","unstructured":"Yeo JM, Carson A, Stone J. Seeing again: treatment of functional visual loss. Pract Neurol. 2019;19:168\u201372.","journal-title":"Pract Neurol"},{"key":"4648_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2215-0366(18)30051-8","volume":"5","author":"L Ludwig","year":"2018","unstructured":"Ludwig L, Pasman JA, Nicholson T, Aybek S, David AS, Tuck S, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry. 2018;5:307\u201320.","journal-title":"Lancet Psychiatry"},{"key":"4648_CR67","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/jnnp-2013-305321","volume":"85","author":"J Gelauff","year":"2014","unstructured":"Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry. 2014;85:220\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04648-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04648-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04648-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:04:28Z","timestamp":1786446268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04648-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4648"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04648-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JS royalties from UpToDate and carries out expert witness work in relation to FND; runs a free website for people with FND,\n                      \n                      ; and is on the FND Society board. The other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}